Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    Why did this record match?
    Reference Devices :

    K102177

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The surgeon's glove is a device made of synthetic rubber latex intended to be worn by surgeons and /or operating room personnel to protect a surgical wound from contamination, and are tested for use with chemotherapy drugs.

    Device Description

    SensiCare® Sterile Powder-Free Polymer Coated Polyisoprene Surgical Glove, Coated with Aloe Vera (Tested for Use with Chemotherapy Drugs)-Natural Color is to function in the same manner as various other surgical gloves existing in industry today. The proposed SensiCare surgical glove is a disposable device made of synthetic rubber latex intended to be worn by surgeons and /or operating room personnel to protect a surgical wound from contamination, and are tested for use with chemotherapy drugs. It has limited contact duration (

    AI/ML Overview

    This document is a 510(k) premarket notification for a medical device: "SensiCare® Sterile Powder-Free Polymer Coated Polyisoprene Surgical Glove, Coated with Aloe Vera (Tested for Use with Chemotherapy Drugs)-Natural Color".

    Here's an analysis of the acceptance criteria and the study that proves the device meets those criteria:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria / Standard (Test Set)Reported Device Performance
    Freedom from Holes:
    ASTM D3577-09eMeets ASTM D3577-09e
    ASTM D5151-06Meets ASTM D5151-06
    Residual Powder:
    ASTM D6124-06 & definition for Powder-Free (≤2 mg/glove)Meets ASTM D6124-06 & definition for Powder-Free; ≤2 mg/glove
    Primary Irritation:
    ISO 10993-10 (No Dermal Irritation Potential)Meets ISO 10993-10; No Dermal Irritation Potential
    Dermal Sensitization:
    ISO 10993-10 (No Sensitization Potential)Meets ISO 10993-10; No Sensitization Potential
    Performance (e.g., Physical Properties):
    ASTM D3577-09eMeets ASTM D3577-09e
    Chemotherapy Drug Permeation (Breakthrough Detection Time - ASTM D6978-05):Meets ASTM D6978-05. Specific times listed below:
    CarmustineAvg. 15.7 minutes (15.7, 16.3, 17.0)
    Cisplatin240 minutes
    Cyclophosphamide (Cytoxan)240 minutes
    Dacarbazine (DTIC)240 minutes
    Doxorubicin Hydrochloride240 minutes
    Etoposide (Toposar)240 minutes
    Fluorouracil240 minutes
    Ifosfamide240 minutes
    Methotrexate240 minutes
    Mitomycin C240 minutes
    Paclitaxel (Taxol)240 minutes
    ThiotepaAvg. 15.3 minutes (15.3, 15.3, 15.3)
    Vincristine Sulfate240 minutes
    Dimensions & Tolerances:
    ASTM D3577-09eMeets ASTM D3577-09e
    FDA Medical Glove Guidance ManualMeets FDA Medical Glove Guidance Manual

    Note: The document explicitly states a "WARNING: Do not use with Carmustine and Thiotepa" despite reporting permeation times, indicating these times are likely too short for safe use.

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not specify the exact sample sizes used for each test (e.g., number of gloves tested for holes, powder, or chemotherapy permeation). It references standards like ASTM D3577-09e, ASTM D5151-06, ASTM D6124-06, and ASTM D6978-05, which would define the required sample sizes for such tests.

    The data provenance is not explicitly stated as "country of origin" or "retrospective/prospective." However, the tests are non-clinical (laboratory-based performance testing of the device itself) and would have been conducted by the manufacturer or a contracted testing facility to demonstrate compliance with the referenced standards.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

    Not applicable. The ground truth for these device performance tests is established by objective, standardized measurements and adherence to specified test methods within the ASTM and ISO standards, rather than expert consensus on interpretation. For example, breakthrough detection time for chemotherapy drugs is a direct measurement, and a glove either passes or fails based on the objective criteria of the standard.

    4. Adjudication Method for the Test Set

    Not applicable. As described above, these are objective performance tests with defined pass/fail criteria from international and national standards (ASTM, ISO). There is no "adjudication" in the sense of reconciling subjective expert opinions.

    5. Multi Reader Multi Case (MRMC) Comparative Effectiveness Study

    No. This document describes the non-clinical performance testing of a surgical glove, not an AI-assisted diagnostic tool. Therefore, a multi-reader multi-case (MRMC) comparative effectiveness study comparing human readers with and without AI assistance is not relevant or applicable.

    6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study

    Not applicable. This is a physical medical device (surgical glove), not a software algorithm. Therefore, "standalone algorithm-only performance" is not relevant.

    7. Type of Ground Truth Used

    The ground truth used for these tests is based on objective, standardized measurements and compliance with established performance criteria defined in international and national standards (ASTM D3577-09e, ASTM D5151-06, ASTM D6124-06, ASTM D6978-05, ISO 10993-10). These are quantifiable metrics (e.g., length, width, thickness, freedom from holes, residual powder, breakthrough detection time, biological response like irritation/sensitization).

    8. Sample Size for the Training Set

    Not applicable. This device is a physical product (surgical glove), not a machine learning model or algorithm that requires a "training set."

    9. How the Ground Truth for the Training Set Was Established

    Not applicable, for the same reason as point 8.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1